SCIRP Mobile Website
Paper Submission

Why Us? >>

  • - Open Access
  • - Peer-reviewed
  • - Rapid publication
  • - Lifetime hosting
  • - Free indexing service
  • - Free promotion service
  • - More citations
  • - Search engine friendly

Free SCIRP Newsletters>>

Add your e-mail address to receive free newsletters from SCIRP.

 

Contact Us >>

Article citations

More>>

Evrard, S., Menetrier-Caux, C., Biota, C., et al. (2007) Cytokines Pattern after Surgical Radiofrequency Ablation of Liver Colorectal Metastases. Gastroentérologie Clinique et Biologique, 31, 141-145.
https://doi.org/10.1016/S0399-8320(07)89344-4

has been cited by the following article:

  • TITLE: Radiofrequency Ablation of Pancreatic Ductal Adenocarcinoma: An Evolving Comrade?

    AUTHORS: Panayiotis Hadjicostas, Demetris Christou, Anastasios Christodoulou

    KEYWORDS: Pancreatic Cancer, Radiofrequency Ablation, Locally Advanced, Surgery

    JOURNAL NAME: Journal of Cancer Therapy, Vol.7 No.13, December 23, 2016

    ABSTRACT: Background: Pancreatic ductal adenocarcinoma (PDAC) presents a challenge for the surgeon due to its aggressiveness and to the stagnation of the management options in cases where complete resection is not feasible. Radiofrequency ablation (RFA) in PDAC is described by a few studies as a promising technique. Methods: We present our 12 years’ experience in locally advanced unresectable PDAC with a series of 19 patients. The mean age was 66.8 years. The mean tumour diameter was 8.1 cm. In all patients, RFA was performed during laparotomy using Cooltip©, in some with IOUS monitoring, followed by palliative bypass procedures. Results: The postoperative period was relatively uneventful. A repeat CT showed remarkable changes in the size and morphology of the tumour. We observed significant improvement in pain relief. The mean survival with the RFA was 19.3 months (6 - 30 months). Conclusions: Our series suggest that RFA for locally advanced and unresectable PDAC in carefully selected patients (excluding multifocal disease) presents a promising, effective and safe associate for the surgeon. RFA plays a complimentary role to current standard palliative therapy, which may prolong survival and improve quality of life. Whether the laparoscopic approach or other non-invasive methods are feasible, will be a challenge for the following years.